PINK:BGMD

Bg Medicine Stock Insider Trading

> Medical - Instruments & Supplies

Buy BGMD

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 03, 2026

BG Medicine Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 4.21M and sold 18.22K BGMD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	4.21M shares
● Sell	18.22K shares
60% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 04, 2016 Buy	Stock option (right to buy) A-Award	Luber Jeffrey R Director	Director	10 000 Value: $3K
Feb 04, 2016 Buy	Common Stock J-Other	Luber Jeffrey R	Director	0 Value: $0
Feb 04, 2016 Buy	Common Stock J-Other	Luber Jeffrey R	Director	0 Value: $0
Feb 04, 2016 Buy	Stock option (right to buy) A-Award	Luber Jeffrey R Director	Director	10 000 Value: $3K
Dec 09, 2015 Sell	Common Stock S-Sale	Afeyan Noubar	Director	2 508 Value: $1K
Dec 09, 2015 Sell	Common Stock S-Sale	Afeyan Noubar	Director	2 508 Value: $1K
Nov 18, 2015 Buy	Stock Option (right to buy) A-Award	Papadopoulos Stelios Director	Director	5 000 Value: $3K
Nov 18, 2015 Buy	Stock Option (right to buy) A-Award	Afeyan Noubar	Director	5 000 Value: $3K
Nov 18, 2015 Buy	Stock Option (right to buy) A-Award	Afeyan Noubar	Director	5 000 Value: $3K
Nov 18, 2015 Buy	Stock Option (right to buy) A-Award	Papadopoulos Stelios Director	Director	5 000 Value: $3K
Jul 27, 2015 Buy	Common Stock X-InTheMoney	Afeyan Noubar	Director	508 Value: $71
Jul 27, 2015 Sell	Common Stock S-Sale	Afeyan Noubar	Director	32 Value: $73
Jul 27, 2015 Buy	Common Stock X-InTheMoney	Afeyan Noubar	Director	254 Value: $36
Jul 27, 2015 Sell	Common Stock S-Sale	Afeyan Noubar	Director	16 Value: $36
Jul 27, 2015 Buy	Common Stock X-InTheMoney	Afeyan Noubar	Director	254 Value: $36
Jul 27, 2015 Sell	Common Stock S-Sale	Afeyan Noubar	Director	16 Value: $36
Jul 27, 2015 Buy	Common Stock X-InTheMoney	Afeyan Noubar	Director	254 Value: $36
Jul 27, 2015 Sell	Common Stock S-Sale	Afeyan Noubar	Director	16 Value: $36
Jul 27, 2015 Buy	Common Stock X-InTheMoney	Afeyan Noubar	Director	254 Value: $36
Jul 27, 2015 Sell	Common Stock S-Sale	Afeyan Noubar	Director	16 Value: $36
Jul 27, 2015 Buy	Common Stock X-InTheMoney	Afeyan Noubar	Director	3 256 Value: $456
Jul 27, 2015 Sell	Common Stock S-Sale	Afeyan Noubar	Director	206 Value: $468
Jul 27, 2015 Sell	Warrant to Purchase Common Stock (right to buy) X-InTheMoney	Afeyan Noubar	Director	508 Value: $71
Jul 27, 2015 Buy	Common Stock X-InTheMoney	Afeyan Noubar	Director	8 410 Value: $1K
Jul 27, 2015 Sell	Common Stock S-Sale	Afeyan Noubar	Director	530 Value: $1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BG MEDICINE, INC

BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the...

Read Full Profile Here